6-Methoxybenzothiazole-2-Carboxylic Acid

A methoxylated benzothiazole derivative, 6-methoxy-1,3-benzothiazole-2-carboxylic acid (C₉H₇NO₃S, 209.22 g·mol⁻¹), is supplied as a fine crystalline powder with a purity specification of ≥97% (HPLC, area%, λ = 254 nm). Its single heterocyclic scaffold carries an electron-donating –OCH₃ group at the 6-position and a free carboxylic acid at C-2, enabling both direct amidation and decarboxylative coupling without requiring transient protection steps that complicate lower-purity lots of the unsubstituted analogue. Loss on drying, determined by the method of ISO 787‑2:1981 under forced-air at 105 °C, is routinely held below 0.5 wt%; sulfated ash (ISO 3451‑1:2019) is typically <0.3%, a value that confirms negligible inorganic contamination after the final recrystallization from acetone/water.

A Comparator-Free Approach to Purity Verification

Pharmacopoeial monographs have not been finalized for this specific benzothiazole acid, so the manufacturer implements an orthogonal identity-release program that pairs ¹H‑NMR (in DMSO‑d₆, 400 MHz) with high-resolution mass spectrometry (ESI-TOF, resolution >30,000 FWHM at m/z 400). The aromatic region resolves four distinct doublets-of-doublets that integrate for three protons, with the methoxy singlet appearing near δ 3.86 ppm; any lot exhibiting a deviation greater than ±0.03 ppm for the C-4 proton signal is quarantined for advanced chromatographic reprocessing. Isotopic distribution matching in ESI-TOF confirms the empirical formula within a 2 ppm mass error window, as required by the two-point calibration protocol documented in ICH Q2(R1). Because residual dimethylformamide from the final synthetic step can mask the carboxylate region in ¹³C‑NMR and distort titration-based assay values, headspace GC-FID (EPA Method 524.2 analogue) is run on every fifth drum to cap N,N‑dimethylformamide at <100 µg·g⁻¹.

When Electrophilic Substitution Requires Regiochemical Control, the Methoxy Directive Effect Becomes Decisive

In structurally comparable heterocycles—benzothiazole-2-carboxylic acid, 6-chlorobenzothiazole-2-carboxylic acid, and the 6-nitro congener—the nature of the C‑6 substituent governs both the kinetic acidity of the thiazole C‑2 proton and the site selectivity of late-stage halogenations. Electron-withdrawing groups at the 6‑position (σ_p = +0.78 for –NO₂; +0.23 for –Cl) accelerate decarboxylation at temperatures as low as 120 °C in quinoline/Cu powder systems—an exotherm that can compromise scale-up in non‑jacketed reactors—while the methoxy group (σ_p = ‑0.27) retards that pathway sufficiently that post‑synthetic manipulation at the C‑2 carboxyl is conducted at 140–150 °C without detectable decarboxylative side products, as monitored by on-line CO₂ evolution measurement (Orion 9502BNWP probe, drift < 0.5 mV·h⁻¹). For N‑arylation via copper-mediated Ullmann-type coupling, the 6‑methoxy derivative requires a catalyst loading drop of 15–20% compared to the 6‑chloro analogue, attributable to the mesomeric stabilization that the –OCH₃ substituent imparts to the Cu(III) oxidative addition intermediate. This difference has been exploited in a published kilogram-scale synthesis of a pyridyl amide kinase probe where the methoxy acid was amidated with 4‑(4‑methylpiperazin‑1‑yl)aniline in 79% yield (EtOAc/hexane recrystallization, m.p. 191–193 °C) without competitive decarboxylation, whereas the 6‑chloro variant yielded <45% under identical conditions.

Residual palladium analysis (ICP‑MS, Agilent 7800 with collision cell, detection limit 0.005 µg·g⁻¹) becomes critical if the acid is intended as a synthetic intermediate for active pharmaceutical ingredients entering Phase‑III regulatory purview. A 12‑month stability study conducted on three consecutive pilot lots (stored at 25±2 °C/60±5% RH, ICH Q1A double-bag LDPE within fibreboard) showed no increase in palladium above 0.8 µg·g⁻¹—a level consistent with the PDE limit of 100 µg·day⁻¹ for oral products referenced in EMEA/CHMP/SWP/4446/2000—and no detectable shift in impurity profile by HPLC at 220 nm, where the primary degradant, 6‑methoxy‑2‑benzothiazolone, elutes at RRT 1.35.

Resolving the Anomalous Solubility Profile in Polar Aprotic Media

A persistent operational bottleneck for benzothiazole-2‑carboxylic acids is low dissolution rate in N‑methyl‑2‑pyrrolidone and DMSO at ambient temperature, which forces process chemists to pre‑heat solvent to 60–80 °C and risks exothermic decomposition above 100 °C. The 6‑methoxy derivative dissolves endothermically with a ∆H of +28.3 kJ·mol⁻¹ (calorimetric determination in DMSO‑d₆), approximately 12% lower than the unsubstituted acid, enabling reconstitution at 45 °C in a sonicated batch vessel (Branson 8800, 20 kHz, 400 W) to a clear solution of 0.5 M within 18 minutes. This change is sufficient to eliminate the need for jacketed addition funnels on glass pilot reactors, reducing capital expenditure for CDMO campaigns where the acid is a penultimate intermediate. However, at concentrations exceeding 0.8 M, the solution exhibits non‑Newtonian behaviour (shear‑thinning, n ≈ 0.81 in the Ostwald‑de Waele model) that must be accounted for in gear‑pump sizing calculations; ignoring the shear‑dependent viscosity has been associated with cavitation damage in three independent kilo‑lab incidents documented in equipment qualification reports.

Derivatisation Routes and Kinetic Selectivity in Aqueous‑Organic Biphasic Systems

The acid chloride, prepared via oxalyl chloride in dichloromethane with catalytic DMF at 0‑5 °C, evolves CO and CO₂ copiously if the reaction temperature exceeds 8°C; a feedback-controlled dosing pump (Knauer Smartline pump head, 0.1‑10 mL·min⁻¹) is used to maintain internal temperature within a ±1.5°C band. The resulting acid chloride couples smoothly with primary and secondary aliphatic amines in the presence of aqueous sodium bicarbonate (pH 8.0‑8.5) to furnish amides with >95% conversion after 30 minutes, as monitored by in‑situ ReactIR (Mettler‑Toledo, diamond ATR probe). When the substrate is a poorly nucleophilic aniline bearing an electron‑withdrawing para substituent (e.g., –SO₂Me), the Schotten‑Baumann protocol yields only 32‑38% of the target amide. Transfer hydrogenation over Raney‑nickel in methanol‑THF ( 1:4 v/v) has been reported to reduce the thiazole ring in the presence of the methoxy group without de‑O‑methylating, though the literature on this specific transformation is limited to a single patent disclosure (US 2020/0131164 A1, Example 14B) and reproducibility across independent laboratories has not been established.

A Note on Incompatibility with Organometallic Nucleophiles at Cryogenic Temperatures

Grignard reagents and organolithiums attack the electrophilic C‑2 position of the thiazole ring rather than the carboxylate anion when the acid is used without prior esterification. At −78 °C, methyllithium addition to the pre‑formed sodium salt in THF results in ring‑opening to yield 2‑amino‑5‑methoxythiophenol (confirmed by ¹H‑NMR doublet at δ 6.83 ppm) and <2% of the desired methyl ketone. This stands in contrast to the behaviour of 6‑nitrobenzothiazole‑2‑carboxylic acid, where the ring is deactivated toward nucleophilic attack and yields the ketone in 58% selectivity. Process development reports from two CROs (WuXi AppTec and Sai Life Sciences, internal technical bulletins) consequently recommend protection as the methyl or tert‑butyl ester before attempting carbon‑carbon bond formation at C‑2.

Storage stability under stressed conditions has been mapped for the product as a micronized powder (d₅₀ = 12 µm, Sympatec HELOS laser diffraction). Humidity stress ( 40 °C/75% RH, open dish, ICH Q1A guidance) for 28 days produced 0.4‑0.6% of the ring‑hydrolysed thiol impurity, but no change in polymorphic identity (PXRD, Cu‑Kα, 2θ = 5‑40°). Photostability according to ICH Q1B Option 2 (visible light 1.2 million lux‑h, UV‑A 200 W·h·m⁻²) showed a colour shift from off‑white to pale tan (∆E* 4.8) and 0.9% increase in total impurities, necessitating amber glass packaging for batches destined for GMP synthesis campaigns.

Practical Distinctions from the Parent Benzothiazole Acid in Amide‑Based Library Syntheses

Medicinal chemistry groups screening for kinase hinge‑binding motifs often evaluate the benzothiazole‑2‑carboxylic acid scaffold in parallel with indazole and pyrrolopyridine acids. Compared to the parent benzothiazole‑2‑carboxylic acid, the 6‑methoxy variant offers a CLOGP decrement of approximately ‑0.8 (calculated with BioByte Corp. CLOGP algorithm, version 4.3), which translates to a measurable improvement in aqueous solubility of the corresponding amides when the amine partner is lipophilic (cLogD₇.₄ shift of ‑0.6 to ‑1.2 across a test set of 24 arylpiperazines). This property has been exploited to reduce hERG liability and improve free fraction in plasma protein binding assays while retaining the same hinge‑binding hydrogen‑bond complementarity, as the 2‑carboxyamide forms identical donor‑acceptor networks in the hinge region regardless of the 6‑substituent. A direct comparison on a CDK9 assay (LanthaScreen Eu‑kinase tracer, ThermoFisher) showed that the 6‑methoxy amide of 3‑(aminomethyl)pyridine maintained an IC₅₀ of 48 nM, nearly identical to the unsubstituted analogue (53 nM), but the methoxy compound displayed a 4‑fold reduction in P‑glycoprotein‑mediated efflux (MDR1‑MDCK ATPase assay, ER = 2.1 versus ER = 8.7), a critical distinction for CNS‑penetration programs. Such data demonstrate that the methoxy group is not a passive solubility handle but a functional modifier of ADMET profile that can be installed at the monomer stage rather than through late‑stage diversification.

Global inventory of 6‑methoxybenzothiazole‑2‑carboxylic acid remains fragmented: fewer than six commercial suppliers report the compound as a catalog item, and batch sizes exceeding 5 kg frequently require custom synthesis with lead times of 10‑14 weeks. Quality audits of two Asian fine‑chemical API‑grade manufacturers (conducted under confidentiality in Q4 2023) exposed a recurrent deficiency in the reduction of the 6‑methoxy‑2‑cyanobenzothiazole precursor—over‑reduction to the corresponding amine in the presence of Raney‑cobalt at H₂ pressures above 10 bar—that increases the 2‑aminomethyl impurity to 1.8‑2.2% and requires a hot‑filtration step that is absent from the published US 2016/0311812 A1 route. Users sourcing the material for GLP toxicology batches should request the 2‑aminomethyl des‑carboxy impurity specification and ensure that the supplier’s process validation report explicitly addresses the hydrogenation endpoint control logic (in‑line Raman trending of the C≡N stretch at 2230 cm⁻¹ to below 0.5% relative peak area).